Safety of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease

Minerva Medica

Volumn 101, Issue 1, 2010, Pages 1-7

  Stricker, R B ^a,b,c   Green, C L ^a,b,c   Savely, V R ^a,b,c   Chamallas, S N ^b,d   Johnson, L ^b,c  

^a Union Square Medical Associates ^*  (United States)

^b International Lyme and Associated Diseases Society   (United States)

^c California Lyme Disease Association   (United States)

^d QMedRx Inc   (United States)

Author keywords

Antibiotic prophylaxis; Borrelia burgdorferi; Complications; Lyme disease

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFOTAXIME; CEFTRIAXONE; CLINDAMYCIN; DIPHENHYDRAMINE; DOXYCYCLINE; ERTAPENEM; HEPARIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; PROBIOTIC AGENT; SODIUM CHLORIDE; TIGECYCLINE; URSODEOXYCHOLIC ACID; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BORRELIA BURGDORFERI; CATHETER INFECTION; CATHETER REMOVAL; CATHETER THROMBOSIS; CHILD; CHOLECYSTITIS; CLINICAL TRIAL; DRUG ERUPTION; DRUG PULSE THERAPY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; INTRAVASCULAR CATHETER; LIVER FUNCTION TEST; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PATIENT MONITORING; PATIENT REFERRAL; RISK REDUCTION; SCHOOL CHILD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKIN PAIN; SKIN SWELLING; TREATMENT DURATION; URTICARIA;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; DRUG ADMINISTRATION SCHEDULE; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; LYME NEUROBORRELIOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; THROMBOSIS; URINARY BLADDER; YOUNG ADULT;

EID: 77952871481     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Johnson L, Stricker RB. Treatment of Lyme disease: A medicolegal assessment. Expert Rev Anti-Infect Ther 2004;2:533-557 (Pubitemid 39162364)
2. Harvey WT, Salvato P. 'Lyme disease': ancient engine of an unrecognized borreliosis pandemic? Med Hypotheses 2003;60:742-759
3. Stricker RB, Lautin A, Burrascano JJ. Lyme disease: point/counterpoint. Expert Rev Anti-Infect Ther 2005;3:155-165
4. Cameron D, Gaito A, Harris N, Bach G, Bellovin S, Bock K et al. Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti-Infect Ther 2004;2(1 Suppl):S1-13.
5. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS et al. The clinical assessment, treatment, and prevention of Lyme disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006;41:1089-1134
6. Patel R, Grogg KL, Edwards WD, Wright AJ, Schwenk NM. Death from inappropriate therapy for Lyme disease. Clin Infect Dis 2000;31:1107-1109 (Pubitemid 32299376)
7. Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med 1998;128:354-362 (Pubitemid 28103103)
8. Ettestad PJ, Campbell GL, Welbel SF, Genese CA, Spitalny KC, Marchetti CM et al. Biliary complications in the treatment of unsubstantiated Lyme disease. J Infect Dis 1995;171:356-361
9. Lightfoot RW, Luft BJ, Rahn DW, Steere AC, Sigal LH, Zoschke DC et al. Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis. Ann Intern Med 1993;119:503-509
10. Fallon BA, Nields JA. Lyme disease: a neuropsychiatric illness. Am J Psychiatry 1994;151:1571-1583
11. Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer E et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 2008;70:992-1003.
12. Stricker RB. Counterpoint: Long-term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clin Infect Dis 2007;45:149-157
13. Garner JP, Macdonald M, Kumar PK. Abdominal actinomycosis. Int J Surg 2007;5:441-448
14. Lazzarini L, Lipsky BA, Mader JT. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis 2005;9:127-138
15. Price VE, Blanchette VS, Ford-Jones EL. The prevention and management of infections in children with asplenia or hyposplenia. Infect Dis Clin North Am 2007;21:697-710, viii-ix.
16. Beytout J, Tournilhac O, Laurichesse H. Antibiotic prophylaxis in splenectomized adults. Presse Med 2003;32(28 Suppl):S17-9. (Pubitemid 37099345)
17. Venneman NG, van Erpecum KJ. Gallstone disease: Primary and secondary prevention. Best Pract Res Clin Gastroenterol 2006;20:1063-1073 (Pubitemid 44793724)
18. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006;101:812-822
19. Maki DG, Kluger DM, Crnich CJ. The risk of blood-stream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006;81:1159-1171
20. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 2007;7:645-657
21. Safdar N, Maki DG. Risk of catheter-related blood-stream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest 2005;128:489-495 (Pubitemid 41140472)
22. James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR; Alberta Kidney Disease Network. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 2008;148:596-605.
23. Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 2001;345:85-92.
24. Krupp LB, Hyman LG, Grimson R, Coyle PK, Melville P, Ahnn S et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 2003;60:1923-1930.
25. Oksi J, Nikoskelainen J, Hiekkanen H, Lauhio A, Peltomaa M, Pitkäranta A et al. Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis 2007;26:571-581
26. Stricker RB, Johnson L. Searching for autoimmunity in "antibiotic-refractory" Lyme arthritis. Mol Immunol 2008;45:3023-3024
27. Stricker RB, Johnson L. Persistent Borrelia burgdorferi infection after treatment with antibiotics and anti-tumor necrosis factor-alpha. J Infect Dis 2008;197:1352-1353 (Pubitemid 351632769)
28. Hodzic E, Feng S, Holden K, Freet KJ, Barthold SW. Persistence of Borrelia burgdorferi following antibiotic treatment in mice. Antimicrob Agents Chemother 2008;52:1728-1736 (Pubitemid 351614666)